RecoveryResearch Phase

Collagen Tripeptide F (CTP-F)

Topical, Subcutaneous injection

Overview

Collagen Tripeptide F is a synthetic tripeptide designed to mimic fragments of native collagen that appear during tissue remodeling. It is hypothesized to bind to fibroblast surface receptors and promote extracellular matrix deposition, thereby accelerating wound healing and connective tissue repair.

Mechanism of Action

The tripeptide structure is intended to enhance bioavailability compared to larger collagen molecules..

Research Summary & Key Findings

Preclinical studies in cell culture and animal wound models have suggested enhanced collagen synthesis and fibroblast proliferation. Clinical trial data in humans remain limited, and peer-reviewed publications documenting efficacy in controlled settings are sparse.

Clinical Status

Research Phase

Collagen Tripeptide F (CTP-F) is in the research phase with limited clinical data in humans. Current evidence is primarily derived from preclinical (animal or in vitro) studies.

Administration Routes

TopicalSubcutaneous injection

Related Peptides in Recovery

Find a Provider

Find a verified provider who offers Collagen Tripeptide F (CTP-F) therapy in your area.

Browse Provider Map

Find a Pharmacy

Browse PCAB-accredited and FDA 503B-registered compounding pharmacies that supply Collagen Tripeptide F (CTP-F).

Pharmacy Directory

Join the Association

Access exclusive peptide protocols, provider resources, and community support.

List Your Practice

Disclaimer: This information is provided for educational and research purposes only. It is not intended as medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any peptide therapy. The Peptide Association does not endorse or recommend any specific treatment protocol.